These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2529295

  • 1. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH, Matuzas W, Glass RM, Easton C.
    J Affect Disord; 1989; 17(3):261-70. PubMed ID: 2529295
    [Abstract] [Full Text] [Related]

  • 2. Maintenance drug therapy of panic disorder.
    Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, Perugi G.
    J Psychiatr Res; 1993; 27 Suppl 1():127-42. PubMed ID: 8145175
    [Abstract] [Full Text] [Related]

  • 3. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
    Lepola UM, Rimón RH, Riekkinen PJ.
    Int Clin Psychopharmacol; 1993 Apr; 8(2):115-8. PubMed ID: 8345160
    [Abstract] [Full Text] [Related]

  • 7. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.
    J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
    [Abstract] [Full Text] [Related]

  • 8. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E, Pohl R, Balon R, Fox I, Rickels K, Yeragani VK.
    Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Nov; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Nov; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 Nov; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 17. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Nov; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 18. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [Abstract] [Full Text] [Related]

  • 19. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
    Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.